These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
528 related items for PubMed ID: 8895319
1. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Arai T, Busby W, Clemmons DR. Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319 [Abstract] [Full Text] [Related]
2. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D. Claussen M, Kübler B, Wendland M, Neifer K, Schmidt B, Zapf J, Braulke T. Endocrinology; 1997 Sep; 138(9):3797-803. PubMed ID: 9275067 [Abstract] [Full Text] [Related]
3. Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts. Conover CA, Khosla S. Growth Horm IGF Res; 2003 Dec; 13(6):328-35. PubMed ID: 14624766 [Abstract] [Full Text] [Related]
4. Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb. Russo VC, Bach LA, Fosang AJ, Baker NL, Werther GA. Endocrinology; 1997 Nov; 138(11):4858-67. PubMed ID: 9348216 [Abstract] [Full Text] [Related]
5. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation. Fowlkes JL, Thrailkill KM, George-Nascimento C, Rosenberg CK, Serra DM. Endocrinology; 1997 Jun; 138(6):2280-5. PubMed ID: 9165012 [Abstract] [Full Text] [Related]
6. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin. Kricker JA, Towne CL, Firth SM, Herington AC, Upton Z. Endocrinology; 2003 Jul; 144(7):2807-15. PubMed ID: 12810534 [Abstract] [Full Text] [Related]
7. Heparin inhibition of insulin-like growth factor-binding protein-3 binding to human fibroblasts and rat glioma cells: role of heparan sulfate proteoglycans. Yang YW, Yanagishita M, Rechler MM. Endocrinology; 1996 Oct; 137(10):4363-71. PubMed ID: 8828497 [Abstract] [Full Text] [Related]
8. Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. Nam TJ, Busby WH, Rees C, Clemmons DR. Endocrinology; 2000 Mar; 141(3):1100-6. PubMed ID: 10698186 [Abstract] [Full Text] [Related]
9. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis. Fowlkes JL, Serra DM, Rosenberg CK, Thrailkill KM. J Biol Chem; 1995 Nov 17; 270(46):27481-8. PubMed ID: 7499205 [Abstract] [Full Text] [Related]
10. Insulin-like growth factor binding protein-4 proteolytic degradation in ovine preovulatory follicles: studies of underlying mechanisms. Mazerbourg S, Zapf J, Bar RS, Brigstock DR, Lalou C, Binoux M, Monget P. Endocrinology; 1999 Sep 17; 140(9):4175-84. PubMed ID: 10465290 [Abstract] [Full Text] [Related]
11. Insulin-like growth factor (IGF)-binding protein-5-(201-218) region regulates hydroxyapatite and IGF-I binding. Campbell PG, Andress DL. Am J Physiol; 1997 Nov 17; 273(5):E1005-13. PubMed ID: 9374688 [Abstract] [Full Text] [Related]